Topolcan O - Search Results

1

Epidemiological and Microbiological Aspects of the Peritonsillar Abscess.

Slouka D, Hanakova J, Kostlivy T, Skopek P, Kubec V, Babuska V, Pecen L, Topolcan O, Kucera R. Slouka D, et al. Among authors: topolcan o. Int J Environ Res Public Health. 2020 Jun 5;17(11):4020. doi: 10.3390/ijerph17114020. Int J Environ Res Public Health. 2020. PMID: 32516939 Free PMC article.

2

Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125.

Nekulova M, Pecen L, Kalabova R, Simickova M, Topolcan O, Pikner R, Vondracek V, Valik D. Nekulova M, et al. Among authors: topolcan o. Clin Chem. 2002 Aug;48(8):1364-7. Clin Chem. 2002. PMID: 12142397 No abstract available.

3

Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases.

Kulda V, Pesta M, Topolcan O, Liska V, Treska V, Sutnar A, Rupert K, Ludvikova M, Babuska V, Holubec L Jr, Cerny R. Kulda V, et al. Among authors: topolcan o. Cancer Genet Cytogenet. 2010 Jul 15;200(2):154-60. doi: 10.1016/j.cancergencyto.2010.04.015. Cancer Genet Cytogenet. 2010. PMID: 20620599

4

Parameters of biological activity in colorectal cancer.

Svobodova S, Topolcan O, Holubec L Jr, Levy M, Pecen L, Svacina S. Svobodova S, et al. Among authors: topolcan o. Anticancer Res. 2011 Jan;31(1):373-8. Anticancer Res. 2011. PMID: 21273626

5

Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancer.

Liska V, Holubec L Jr, Treska V, Vrzalova J, Skalicky T, Sutnar A, Kormunda S, Bruha J, Vycital O, Finek J, Pesta M, Pecen L, Topolcan O. Liska V, et al. Among authors: topolcan o. Anticancer Res. 2011 Apr;31(4):1447-51. Anticancer Res. 2011. PMID: 21508401

6

Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study.

Pazdiora P, Svobodova S, Fuchsova R, Kucera R, Prazakova M, Vrzalova J, Narsanska A, Strakova M, Treskova I, Pecen L, Treska V, Holubec L Jr, Pesek M, Finek J, Topolcan O. Pazdiora P, et al. Among authors: topolcan o. Anticancer Res. 2011 Oct;31(10):3619-21. Anticancer Res. 2011. PMID: 21965787

7

Prognostic significance of TIMP-1 in non-small cell lung cancer.

Pesta M, Kulda V, Kucera R, Pesek M, Vrzalova J, Liska V, Pecen L, Treska V, Safranek J, Prazakova M, Vycital O, Bruha J, Holubec L, Topolcan O. Pesta M, et al. Among authors: topolcan o. Anticancer Res. 2011 Nov;31(11):4031-8. Anticancer Res. 2011. PMID: 22110238

8

Growth factors and breast tumors, comparison of selected growth factors with traditional tumor markers.

Kucera R, Cerna M, Narsanska A, Svobodova S, Strakova M, Vrzalova J, Fuchsova R, Treskova I, Kydlicek T, Treska V, Pecen L, Topolcan O, Pazdiora P. Kucera R, et al. Among authors: topolcan o. Anticancer Res. 2011 Dec;31(12):4653-6. Anticancer Res. 2011. PMID: 22199345

9

HE4 and ROMA index in Czech postmenopausal women.

Novotny Z, Presl J, Kucera R, Topolcan O, Vrzalova J, Fuchsova R, Betincova L, Rokyta Z. Novotny Z, et al. Among authors: topolcan o. Anticancer Res. 2012 Sep;32(9):4137-40. Anticancer Res. 2012. PMID: 22993374

10

Plasma TIMP1 level is a prognostic factor in patients with liver metastases.

Bunatova K, Pesta M, Kulda V, Topolcan O, Vrzalova J, Sutnar A, Treska V, Pecen L, Liska V. Bunatova K, et al. Among authors: topolcan o. Anticancer Res. 2012 Oct;32(10):4601-6. Anticancer Res. 2012. PMID: 23060593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters